首页> 外文OA文献 >Phase II Trial of Dendritic Cells Loaded with Antigens from Self-Renewing, Proliferating Autologous Tumor Cells as Patient-Specific Antitumor Vaccines in Patients with Metastatic Melanoma: Final Report

【2h】

Phase II Trial of Dendritic Cells Loaded with Antigens from Self-Renewing, Proliferating Autologous Tumor Cells as Patient-Specific Antitumor Vaccines in Patients with Metastatic Melanoma: Final Report

机译：抗原的树突细胞的II期试验从自我更新，激增自体肿瘤细胞作为转移性黑素瘤患者的患者特异性抗肿瘤疫苗：最终报告

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Robert O. Dillman; Senthamil R. Selvan; Patric M. Schiltz; Edward F. McClay; Neil M. Barth; Carol DePriest; Cristina de Leon; Cheryl Mayorga; Andrew N. Cornforth; Kanoe Allen;
展开▼
作者单位

展开▼
年度 2009
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Phase II trial of dendritic cells loaded with antigens from self-renewing, proliferating autologous tumor cells as patient-specific antitumor vaccines in patients with metastatic melanoma: final report. [J] . Dillman RO, Selvan SR, Schiltz PM Cancer biotherapy and radiopharmaceuticals . 2009,第3期

机译：在转移性黑素瘤患者中，树突状细胞负载自更新的，增殖的自体肿瘤细胞作为患者特异性抗肿瘤疫苗的抗原的II期试验：最终报告。
2. Superiority of dendritic cell vaccine vs tumor cell vaccine: survival by stratification subsets in MACVAC randomized Phase II trial of patient-specific vaccines utilizing antigens from autologous melanoma tumor cell lines [J] . Robert O Dillman, Edward McClay, Thomas Amatruda, Journal for ImmunoTherapy of Cancer . 2015,第S2期

机译：树突状细胞疫苗相对于肿瘤细胞疫苗的优越性：利用自体黑素瘤肿瘤细胞系抗原的患者特异性疫苗的MACVAC随机II期临床试验中的分层亚群存活
3. Phase I/II trial of melanoma patient-specific vaccine of proliferating autologous tumor cells, dendritic cells, and GM-CSF: planned interim analysis. [J] . Dillman R, Selvan S, Schiltz P, Cancer biotherapy and radiopharmaceuticals . 2004,第5期

机译：黑色素瘤患者特异性疫苗增殖自体肿瘤细胞，树突状细胞和GM-CSF的I / II期试验：计划中的中期分析。
4. CD40-ACTIVATED B (CD40-B) CELLS LOADED WITH AUTOLOGOUS TUMOR RNA AS A NOVEL ANTIGEN-PRESENTING CELL VACCINE FOR CANINE LYMPHOMA [C] . Amy LaBlanc, Erika L Krick, Beth Overley, Annual conference of the Veterinary Cancer Society . 2008

机译：CD40-活化的B（CD40-B）用自体肿瘤RNA负载，作为犬淋巴瘤的新型抗原呈递细胞疫苗
5. Potentiation of the immune response with aluminum-containing adjuvants: I. Distribution of adsorbed antigen in mono-valent and combination vaccines; II. Role of antigen adsorption in antigen internalization by dendritic cells. [D] . Morefield, Garry Lee, Jr. 2003

机译：含铝佐剂增强免疫应答：I.单价和组合疫苗中吸附抗原的分布；二。抗原吸附在树突状细胞的抗原内在化中的作用。
6. Superiority of dendritic cell vaccine vs tumor cell vaccine: survival by stratification subsets in MACVAC randomized Phase II trial of patient-specific vaccines utilizing antigens from autologous melanoma tumor cell lines [O] . Robert O Dillman, Edward McClay, Thomas Amatruda, 2015

机译：树突状细胞疫苗相对于肿瘤细胞疫苗的优越性：利用自体黑素瘤肿瘤细胞系抗原的患者特异性疫苗的MACVAC随机II期临床试验中的分层亚群存活
7. Superiority of dendritic cell vaccine vs tumor cell vaccine: survival by stratification subsets in MACVAC randomized Phase II trial of patient-specific vaccines utilizing antigens from autologous melanoma tumor cell lines [O] . 2015

机译：树突状细胞疫苗相对于肿瘤细胞疫苗的优越性：利用自体黑素瘤肿瘤细胞系抗原的患者特异性疫苗的MACVAC随机II期临床试验中的分层亚群存活

Phase II Trial of Dendritic Cells Loaded with Antigens from Self-Renewing, Proliferating Autologous Tumor Cells as Patient-Specific Antitumor Vaccines in Patients with Metastatic Melanoma: Final Report

著录项

引文网络

相似文献

相关主题

期刊订阅